ADC Therapeutics SA (ADCT)
1.44
-0.16
(-10.00%)
USD |
NYSE |
Oct 23, 16:00
1.44
0.00 (0.00%)
Pre-Market: 20:00
ADC Therapeutics Profit Margin (Quarterly) : -86.06% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -86.06% |
| March 31, 2026 | -158.1% |
| December 31, 2025 | -27.80% |
| September 30, 2025 | -249.4% |
| June 30, 2025 | -300.7% |
| March 31, 2025 | -167.6% |
| December 31, 2024 | -181.7% |
| September 30, 2024 | -238.1% |
| June 30, 2024 | -209.9% |
| March 31, 2024 | -258.2% |
| December 31, 2023 | -506.4% |
| Date | Value |
|---|---|
| September 30, 2023 | -322.4% |
| June 30, 2023 | -253.7% |
| March 31, 2023 | -312.6% |
| December 31, 2022 | -33.45% |
| September 30, 2022 | -66.31% |
| June 30, 2022 | -372.3% |
| March 31, 2022 | -35.83% |
| December 31, 2021 | -202.1% |
| September 30, 2021 | -544.2% |
| June 30, 2021 | -1.93K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 13.90% |
| AC Immune SA | 12.40% |
| CRISPR Therapeutics AG | -895.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.17% |
| Return on Invested Capital | -94.23% |
| Gross Profit Margin (Quarterly) | 87.80% |
| Operating Margin (Quarterly) | -117.9% |
| Return on Net Operating Assets | -219.6% |